Regeneron Pharmaceuticals (REGN) Other financing activities (2013 - 2025)

Regeneron Pharmaceuticals' Other financing activities history runs 6 years deep, the most recent figure standing at -$10.3 million for Q1 2025.

• In Q1 2025, Other financing activities changed N/A year-over-year to -$10.3 million; the TTM figure through Dec 2025 stood at -$10.3 million (up 69.16% YoY), while the FY2025 annual figure was -$10.3 million, up 69.16% from the prior year.
• Other financing activities for Q1 2025 stood at -$10.3 million, up from -$33.4 million in the prior quarter.
• The five-year high for Other financing activities was -$10.3 million in Q1 2025, with the low at -$33.4 million in Q3 2024.